Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 13/20 | 0.54 |
| ▸ | BCL2 | P10415 | 17/20 | 0.49 |
| ▸ | BAD | Q92934 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17955549 | 0.81 | BCL2L1 (0.66) | BCL2L1BCL2BAD | |
| SCHEMBL29403793 | 0.81 | BCL2L1 (0.80) | BCL2L1BCL2BAD | |
| SCHEMBL22581252 | 0.81 | BCL2L1 (0.80) | BCL2L1BCL2BAD | |
| SCHEMBL22581251 | 0.81 | BCL2L1 (0.80) | BCL2L1BCL2BAD | |
| SCHEMBL28483147 | 0.78 | BCL2L1 (0.83) | BCL2L1BCL2BAD | |
| SCHEMBL22879236 | 0.78 | BCL2L1 (0.61) | BCL2L1BCL2BAD | |
| SCHEMBL19014621 | 0.77 | BCL2L1 (0.57) | BCL2L1BCL2BAD | |
| SCHEMBL22581196 | 0.77 | BCL2L1 (0.77) | BCL2L1BCL2BAD | |
| SCHEMBL22581194 | 0.77 | BCL2L1 (0.77) | BCL2L1BCL2BAD | |
| SCHEMBL29424536 | 0.77 | BCL2L1 (0.77) | BCL2L1BCL2BAD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117866015-A | Compound used in clinical management and application thereof | 联合生物科技公司 | 2024-04-12 | — | — | CN | claimed |
| CN-112513057-B | Acylaminophosphonates and acylbenzylamines as Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for use in the treatment of cancer | 联合生物科技公司 | 2024-01-05 | — | — | CN | claimed |
| CN-117866015-A | Compound used in clinical management and application thereof | 联合生物科技公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-112513057-B | Acylaminophosphonates and acylbenzylamines as Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for use in the treatment of cancer | 联合生物科技公司 | 2024-01-05 | — | — | CN | disclosed |